The $16M USD round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai; OneCell to continue transforming the future of precision oncology with U.S. market entry

The Chandler Arizonan

Chandler

Maricopa County

Arizona

United States

OneCell Diagnostics, Inc.  Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology

Media Bias/Fact Check

Queen Creek Tribune

Queen Creek

The $16M USD round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai; OneCell to continue transforming the future of precision oncology with U.S. market entry CUPERTINO, Calif. and MUMBAI, India, Nov. 21, 2024 /PRNewswire/ — OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round led by Celesta Capital, with participati…

Businessfortnight

Latest News OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology - Businessfortnight

Cancer diagnostics startup OneCell Diagnostics has raised $16 million in its Series A round led by Celesta Capital. Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures have also participated in the round. The proceeds will be used to expand to the US market for OncoIndx Alfa, a next-generation liquid biopsy test that detects circulating tumor cells, OneCell said in a press release. Founded in 2021, OneCell’s technology uses next-ge…

Entrackr

OneCell Diagnostics raises $16 Mn in Series A round

fundingblogger.com

The AI Journal

OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology

What You Should Know: – OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures.  – The funding will be used to advance its vision of democratizing precision oncology through cancer diagnostic testing that is more accessible, actionable, and…

hitconsultant.net

OneCell Diagnostics Raises $16M for Genomics-Based Precision Oncology Platform

OneCell Diagnostics has created advanced liquid biopsy technology that redefines cancer screening. This funding aims to make cancer diagnostics accessible and affordable.

Business Review Live | Business News, Reviews | Entrepreneur Stories, Interviews | Kerala | India |

OneCell Diagnostics raises $16M in Series A round | Business Review Live | Business News, Reviews | Entrepreneur Stories, Interviews

OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics